IRD

OPUS GENETICS INC

IRD·67577R102·US·Common Stock·Healthcare - Biotechnology-Activist

IRD (OPUS GENETICS INC) is held by 44 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($27.4M), BALYASNY ASSET MANAGEMENT L.P. ($12.4M), MILLENNIUM MANAGEMENT LLC ($12M). Net institutional sentiment: Mixed.

44
Holders
Avg rating(10 Elite)
$103.1M
Total Value
65% (48)
Fund Consensus
26 buying - 14 selling
IRDSmart Money Verdict
View all
Held by 44 funds
10 elite
Who's Trading
ActivistFFFoundation Fighting Blindness Retinal Degeneration Fund4.7%May 20, 2026
InsiderFFFoundation Fighting Blindness Retinal Degeneration FundSell $7.4MMay 18, 2026
ActivistBalyasny Asset Management L.P.Balyasny Asset Management L.P.7.2%May 15, 2026
ActivistNANantahala Capital Management, LLC6.5%May 15, 2026
ActivistPAPerceptive Advisors LLC10.0%May 15, 2026
ActivistCACaligan Partners LP8.5%May 15, 2026
ActivistADAdage Capital Management, L.P.8.5%May 13, 2026
InsiderMGMagrath GeorgeSell $50KApr 23, 2026
InsiderYRYERXA BENJAMIN RSell $39KApr 23, 2026
InsiderGEGagnon Robert E.Sell $41KApr 23, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6M(+445.7%)$27.4M0.0%+3.07%
46
Unchanged
2.7M$12.4M0.0%+101.03%
0
Increased
2.6M(+31.4%)$12M0.0%+56.86%
35
New
2.4M$11.1M0.0%-7.76%
38
Increased
2.3M(+1367.4%)$10.5M0.0%-4.23%
45
New
1.4M$6.2M0.0%-7.76%
38
New
1M$4.6M0.0%-7.76%
37
Increased
823,383(+308.4%)$3.7M0.0%+6.92%
43
Increased
538,347(+6.6%)$2.5M0.0%+45.01%
28
New
388,491$1.8M0.0%-7.76%
36
New
326,809$1.5M0.0%-7.76%
35
New
281,801$1.3M0.0%-7.76%
35
Increased
257,649(+186.9%)$1.2M0.0%+13.76%
41
Increased
199,953(+15.4%)$909,7860.0%+52.51%
20
New
158,103$719,3690.0%-7.76%
34
Increased
147,740(+4.1%)$672,2170.0%+119.98%
17
Unchanged
128,366$584,0650.0%+118.99%
0
Decreased
120,900(-33.1%)$550,0950.0%+111.94%
0
Decreased
108,641(-28.2%)$494,3170.0%+141.93%
0
Increased
94,415(+8.0%)$429,5880.0%+76.16%
26

Showing 1-20 of 48

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used